L’association P1.5 a publié les articles scientifiques suivants :
Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice. Acta Ophthalmol. 2013;91(7):e584-6.
Anatomical and functional prognosis of secondary retinal detachments after sutureless macular surgery. J Fr Ophtalmol. 2014;37(1):58-63.
Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema. Ophthalmologica. 2015;233:169-75.
Dexamethasone Implants in Patients with Naive Diabetic Macular Edema. Ophthalmologica. 2016;235(4):244.
Long-Term Real-Life Efficacy and Safety of Repeated Ozurdex® Injections and Factors Associated with Macular Edema Resolution after Retinal Vein Occlusion: The REMIDO 2 Study. Ophthalmologica. 2016;236(4):186-192.
Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema. Eur J Ophthalmol. 2016 ;4;26(5):454-9.
Recurrences of retinal detachment after retinectomy : causes and outcomes. Retina. 2020;40(7):1315-1324.
FIL-SSF Carlevale intraocular lens for sutureless scleral fixation: 7 recommendations from a serie of 72 cases. MICA study (Multicentric Study of the Carlevale IOL). J Fr Ophtalmol. 2021;44(7):1038-1046.
A retrospective, multicenter study on the management of macular holes without residual internal limiting membrane: the refractory macular hole (ReMaHo) study. Graefes Arch Clin Exp Ophthalmol. 2022;260(12):3837-3845.
Association P1.5 